FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045676922> ?p ?o ?g. }

• W2045676922 endingPage "1932" @default.
• W2045676922 startingPage "1929" @default.
• W2045676922 abstract "Cytidine deaminases of the APOBEC family (ApoB mRNA editing catalytic subunit) generate targeted damage in nucleic acids by deaminating cytosins to uracils. The catalytically active family members are APOBEC1, APOBEC3 proteins (which comprise APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H) and activation-induced deaminase (AID) (reviewed in Conticello1, 2). APOBEC1 deaminates the mRNA for Apolipoprotein B thereby generating ApoB48, which mediates the absorption of dietary lipid from the intestine.3 Whereas APOBEC3 proteins are implicated in the natural defense against retroviruses and mobile elements by mutating and thereby inactivating retroviral single stranded DNA intermediates, AID mediates somatic hypermutation and class switch recombination of immunoglobulin genes in B cells.4 As it was shown that AID can cause substantial off-target DNA damage, AID has been implicated in B-cell lymphomagenesis by mutating oncogenes and by mediating chromosomal translocations as side product of aberrant class switch recombination.5 In chronic lymphocytic leukemia (CLL), previous reports have described the presence of AID transcripts in a subset of CLL patients where AID-expressing CLL patients exhibited a significantly decreased time to treatment and overall survival.6 Paradoxically, AID levels were higher in CLL cells expressing unmutated immunoglobulin variable domains (IgV-UM) encoding the B-cell antigen receptor, which predicts for poor prognosis, whereas CLL cells with somatically hypermutated IgV (IgV-Mut) tend to have lower AID transcript abundances.7 Also, AID expression associates with complex genomic aberrations and with Richter's transformation to a more aggressive disease,8 providing strong evidence that AID is implicated in clonal evolution and pathogenesis in CLL. However, recent studies have revealed that other APOBEC family members are as well implicated in cancer development by inducing genome wide C>U deaminations that turn to C>T transition mutations after DNA replication.9 It was found that APOBEC-mediated mutations can lead to mutation showers (termed kataegis) in which multiple mutations are spaced by only one to several hundred nucleotides.10In CLL, kataegic events were recently described that exhibit a signature of AID-mediated hypermutation.11 These clustered mutations are mostly but not exclusively found within the Ig locus and are restricted to IgV-Mut CLL cases.11 To compare clustered mutations inside and outside the Ig locus, we reanalyzed CLL whole genome sequencing data from Puente and coworkers, who sequenced two IgV-UM and two IgV-Mut CLL samples (Supplementary Table 6 from Puente et al.12). We thereby found that genome-wide mutations had a mean intermutational distance from 2.8 Mb (95% confidence interval: 2.698–2.937 Mb), which was similar for IgV-Mut and IgV-UM samples (Figure 1a). By searching for clustered mutations with intermutational distances below 10 kb, we noticed that while the two IgV-UM samples did not harbor mutation foci (defined as ⩾3 mutations each spaced by ⩽10 kb), the two IgV-Mut samples exhibited 19 clusters with a total of 113 (5.4% of total) mutations where ⩾3 mutations were spaced with an intermutational distance below 10 kb (Figure 1a). From these clusters, 49 mutations (43%) were located within the Ig locus and 64 (57%) were located outside the Ig locus (Figure 1a and Supplementary Table 1). In contrast to kataegis described in breast cancer,11 the clustered mutations found in CLL do not have a particular bias toward C>T or C>G mutations, neither at Ig nor at non-Ig clusters Supplementary Table 1), but rather have a mutation feature typical for somatic hypermutation where AID-mediated cytidine deamination is processed by error prone polymerases.4, 11 In line with this, C>T transitions within clustered mutations at the Ig loci were confined to the AID hot spot motif WRCY (W=A or T; R=A or G; Y=C or T; Figure 1c). In contrast, C>T transitions at mutation clusters outside the Ig locus were primarily found at TCW motifs, which is no AID but an APOBEC3 mutation motif (Figure 1c).10 Genome-wide unclustered C>T mutations outside mutation foci did not show a certain motif bias, neither when all CpGs or CpG islands were excluded from the analysis, as methylated cytosines (which are confined to CpG dinucleotides) are more prone to spontaneous deamination than normal cytosines13 (Figure 1b). Apart from the APOBEC3 motif at C>T transitions within clustered mutations at non-Ig loci, the spectrum of mutations was quite similar to hypermutation at Ig loci, with no apparent sequence bias (Supplementary Table 1). Thus, it is tempting to speculate that in CLL, APOBEC3 might operate in combination with factors of the hypermutation machinery to induce off-target DNA damage at non-Ig loci.Figure 1Clustered mutations are present in IgV-Mut CLL samples. (a) Analysis of whole genome sequencing data by rainfall plots shows intermutational distances (IMDs) in four individual CLL cases with unmutated (CLL1 and 2) and mutated IgV (CLL3 and 4). Mutations ...As our mutation analysis revealed that C>T transitions within small mutation clusters occur at APOBEC3 recognition motifs outside the Ig loci in CLL, we next asked whether any APOBEC members are expressed in CLL samples. We therefore measured transcript levels of catalytically active members APOBEC3A to APOBEC3H using SYBR green quantitative reverse transcription (qRT)-PCR in a set of 10 IgV-Mut and 8 IgV-UM CLL samples and compared values with that from purified B cells of 5 healthy controls. As shown in Figure 2a, we found that APOBEC3A, APOBEC3B and APOBEC3H were expressed in CLL samples with a slight upregulation compared with healthy controls (Figure 2a). In addition, we observed a slight but significant difference in APOBEC3A, APOBEC3B and APOBEC3H expression values between IgV-Mut or IgV-UM samples (APOBEC3A: median 2.87 vs 1.92, P=0.016; APOBEC3B: median 1.37 vs 0.82, P=0.034; APOBEC3H: median 4.66 vs 2.77, P=0.021; Figure 2a). We subsequently tested protein expression of APOBEC3A, APOBEC3B and APOBEC3H by immunoblotting and found bands corresponding to APOBEC3A and APOBEC3B in almost any CLL sample irrespective of IgV mutation status (Figure 2b). Although median expression values of APOBEC3A and APOBEC3B were 1.5 and 1.7 times higher in IgV-Mut compared with IgV-UM CLL samples in qRT-PCR, this difference was too small to be discerned in immunoblotting on the level of protein. APOBEC3H, albeit showing highest expression in qRT-PCR, did not show detectable protein amounts in immunoblotting. A faint band for APOBEC3H that appeared in MEC1 cell lysates served as positive control (Figure 2b). Upon stimulation of CLL cells with CpG, APOBEC3B protein was upregulated, while APOBEC3A remained quite constant or even showed reduced band intensities in immunoblotting (Figure 2b). The APOBEC member AID was only detectable on in vitro stimulation of cells with CpG before cell lysis in one IgV-Mut and one IgV-UM sample, respectively (Figure 2b).Figure 2APOBEC3 family members are expressed in CLL. (a) SYBR green qRT-PCR data from cDNA of 10 IgV-Mut, 8 IgV-UM CLL samples and 5 healthy controls (HD) using APOBEC3A-H (abbreviated: A3A-H)-specific primer sets normalized to glyceraldehyde 3-phosphate dehydrogenase ...Overall, our data show that aside of AID, also APOBEC3 deaminases are likely implicated in mediating off-target mutations in CLL. We show that APOBEC3A and APOBEC3B are more abundant on protein level in CLL than in AID, and clustered genomic C>T mutations outside the Ig locus occur at APOBEC3 hot spot motifs in IgV-Mut CLL. As these clustered mutations were confined to IgV-Mut samples, we initially suspected that APOBEC3 members were differentially expressed according to the IgV mutation status. However, although APOBEC3A, APOBEC3B and APOBEC3H transcripts were significantly lower expressed in IgV-UM samples, it is questionable whether this small difference has biological significance, as APOBEC3A and APOBEC3B were easily detectable on the protein level in both IgV-Mut as well as IgV-UM samples. However, as it was shown that APOBEC3 levels correlate with APOBEC3-induced mutations,14 it is conceivable that even small differences in APOBEC3 expression levels could account for the observed difference in APOBEC3-induced clustered mutations in IgV-Mut vs IgV-UM CLL (Figure 2a). Alternatively, as recent studies have revealed that apart from APOBEC expression additional factors of the DNA repair machinery10 are required for inducing kataegis, our data could suggest that any of these factors are not expressed in IgV-UM samples, similar to the observation that AID expression in IgV-UM CLL samples is not sufficient to diversify IgV genes.7 The absence of any of these factors could either alter the targeting of APOBEC3 to the DNA or otherwise affect the error prone DNA repair of APOBEC3-induced DNA lesions. Hence, it is conceivable that APOBEC3 might operate non-processively in IgV-UM CLL, resulting in the generation of unclustered mutations as opposed to clustered kataegic events in IgV-Mut CLL. From our data we conclude that aside of AID, also APOBEC3 should be considered as a source for genomic mutations in CLL. As CLL has a substantial intraclonal heterogeneity,15 we suspect that ongoing APOBEC3 expression might contribute to this genetic complexity by continuously increasing the mutation load, thereby accelerating clonal evolution to a more aggressive or chemorefractory disease. We further propose that analyzing IgV-Mut vs IgV-UM CLL will likely yield a deeper insight into mechanisms that underlie the initiation of APOBEC3-mediated clustered vs unclustered DNA mutations in cancer in general." @default.
• W2045676922 created "2016-06-24" @default.
• W2045676922 creator A5016561809 @default.
• W2045676922 creator A5020018750 @default.
• W2045676922 creator A5039161696 @default.
• W2045676922 creator A5039625974 @default.
• W2045676922 creator A5039994927 @default.
• W2045676922 creator A5041636729 @default.
• W2045676922 creator A5045993698 @default.
• W2045676922 creator A5048660504 @default.
• W2045676922 creator A5090262820 @default.
• W2045676922 date "2014-05-20" @default.
• W2045676922 modified "2023-10-11" @default.
• W2045676922 title "APOBEC3 signature mutations in chronic lymphocytic leukemia" @default.
• W2045676922 cites W1930479567 @default.
• W2045676922 cites W1977319443 @default.
• W2045676922 cites W1984236815 @default.
• W2045676922 cites W1993355130 @default.
• W2045676922 cites W2003665515 @default.
• W2045676922 cites W2004467116 @default.
• W2045676922 cites W2004722288 @default.
• W2045676922 cites W2009953267 @default.
• W2045676922 cites W2010665178 @default.
• W2045676922 cites W2088580309 @default.
• W2045676922 cites W2101836667 @default.
• W2045676922 cites W2122883276 @default.
• W2045676922 cites W2152061559 @default.
• W2045676922 cites W2171690009 @default.
• W2045676922 cites W80520427 @default.
• W2045676922 doi "https://doi.org/10.1038/leu.2014.160" @default.
• W2045676922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4140768" @default.
• W2045676922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24840555" @default.
• W2045676922 hasPublicationYear "2014" @default.
• W2045676922 type Work @default.
• W2045676922 sameAs 2045676922 @default.
• W2045676922 citedByCount "20" @default.
• W2045676922 countsByYear W20456769222014 @default.
• W2045676922 countsByYear W20456769222015 @default.
• W2045676922 countsByYear W20456769222016 @default.
• W2045676922 countsByYear W20456769222017 @default.
• W2045676922 countsByYear W20456769222018 @default.
• W2045676922 countsByYear W20456769222019 @default.
• W2045676922 countsByYear W20456769222020 @default.
• W2045676922 countsByYear W20456769222021 @default.
• W2045676922 crossrefType "journal-article" @default.
• W2045676922 hasAuthorship W2045676922A5016561809 @default.
• W2045676922 hasAuthorship W2045676922A5020018750 @default.
• W2045676922 hasAuthorship W2045676922A5039161696 @default.
• W2045676922 hasAuthorship W2045676922A5039625974 @default.
• W2045676922 hasAuthorship W2045676922A5039994927 @default.
• W2045676922 hasAuthorship W2045676922A5041636729 @default.
• W2045676922 hasAuthorship W2045676922A5045993698 @default.
• W2045676922 hasAuthorship W2045676922A5048660504 @default.
• W2045676922 hasAuthorship W2045676922A5090262820 @default.
• W2045676922 hasBestOaLocation W20456769221 @default.
• W2045676922 hasConcept C104317684 @default.
• W2045676922 hasConcept C194409129 @default.
• W2045676922 hasConcept C203014093 @default.
• W2045676922 hasConcept C2524010 @default.
• W2045676922 hasConcept C2777938653 @default.
• W2045676922 hasConcept C2778461978 @default.
• W2045676922 hasConcept C2779696439 @default.
• W2045676922 hasConcept C33923547 @default.
• W2045676922 hasConcept C501734568 @default.
• W2045676922 hasConcept C502942594 @default.
• W2045676922 hasConcept C54355233 @default.
• W2045676922 hasConcept C71924100 @default.
• W2045676922 hasConcept C86803240 @default.
• W2045676922 hasConceptScore W2045676922C104317684 @default.
• W2045676922 hasConceptScore W2045676922C194409129 @default.
• W2045676922 hasConceptScore W2045676922C203014093 @default.
• W2045676922 hasConceptScore W2045676922C2524010 @default.
• W2045676922 hasConceptScore W2045676922C2777938653 @default.
• W2045676922 hasConceptScore W2045676922C2778461978 @default.
• W2045676922 hasConceptScore W2045676922C2779696439 @default.
• W2045676922 hasConceptScore W2045676922C33923547 @default.
• W2045676922 hasConceptScore W2045676922C501734568 @default.
• W2045676922 hasConceptScore W2045676922C502942594 @default.
• W2045676922 hasConceptScore W2045676922C54355233 @default.
• W2045676922 hasConceptScore W2045676922C71924100 @default.
• W2045676922 hasConceptScore W2045676922C86803240 @default.
• W2045676922 hasIssue "9" @default.
• W2045676922 hasLocation W20456769221 @default.
• W2045676922 hasLocation W20456769222 @default.
• W2045676922 hasLocation W20456769223 @default.
• W2045676922 hasLocation W20456769224 @default.
• W2045676922 hasOpenAccess W2045676922 @default.
• W2045676922 hasPrimaryLocation W20456769221 @default.
• W2045676922 hasRelatedWork W1963572254 @default.
• W2045676922 hasRelatedWork W2025965695 @default.
• W2045676922 hasRelatedWork W2032200822 @default.
• W2045676922 hasRelatedWork W2063717733 @default.
• W2045676922 hasRelatedWork W2162794727 @default.
• W2045676922 hasRelatedWork W2751117019 @default.
• W2045676922 hasRelatedWork W2883739273 @default.
• W2045676922 hasRelatedWork W3030386400 @default.
• W2045676922 hasRelatedWork W4254240245 @default.
• W2045676922 hasRelatedWork W88401132 @default.

• next